CompletedNCT00666731
Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer
Studying Hereditary breast cancer
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Nebraska
- Principal Investigator
- Kenneth H Cowan, MD, PhDUniversity of Nebraska
- Intervention
- medical chart review(other)
- Enrollment
- 4945 enrolled
- Eligibility
- 19-120 years · All sexes
- Timeline
- 2006 – 2016
Study locations (30)
- Penrose Cancer Center, Colorado Springs, Colorado, United States
- Centura - Porter Adventist Hospital, Denver, Colorado, United States
- Centura - St. Anthony Hospital, Lakewood, Colorado, United States
- Centura - Parker Adventist Hospital, Parker, Colorado, United States
- Centura - St. Mary Corwin Medical Center, Pueblo, Colorado, United States
- Halifax Health Medical Center, Daytona Beach, Florida, United States
- Florida Hospital Memorial Medical Center, Daytona Beach, Florida, United States
- Hlaifax Health Medical Center, Daytona Beach, Florida, United States
- Florida Hospital Deland, DeLand, Florida, United States
- Florida Hospital FISH, Orange City, Florida, United States
- Halifax Health Medical Center, Ormond Beach, Florida, United States
- Florida Hospital Flagler, Palm Coast, Florida, United States
- Rush-Copley Cancer Care Center, Aurora, Illinois, United States
- Trinity Medical Center, Moline, Illinois, United States
- Rush-Copley Healthcare Center, Yorkville, Illinois, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00666731 on ClinicalTrials.govOther trials for Hereditary breast cancer
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT07558733Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast CancerFaeth Therapeutics
- RECRUITINGNANCT07436312Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of CancerGustave Roussy, Cancer Campus, Grand Paris
- RECRUITINGNANCT07307664Increasing Germline Genetic Testing for Patients With CancerJosh Peterson
- RECRUITINGNCT07532434A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian CancerPeking University Third Hospital
- RECRUITINGNANCT07292246A Prospective CohorT Study of HandX - Assisted ENdoscopic MAstectomy: Feasibility and Safety (ATHENA I Study)Vasileios Kalles
- RECRUITINGPHASE2NCT07162298Dragon Boat Race Versus Family Unsupervised Training to Improve the Physical Function and Quality of Life in Breast Cancer PatientsFirst Affiliated Hospital of Zhejiang University
- RECRUITINGNANCT06760507Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health ClinicsEmory University
- RECRUITINGNANCT05898009Contribution of Oncogenetics in Breast Cancer in Reunion Epidemiology of Breast Cancer in Reunion: Study of the Reunion Mutation on BRCA2Centre Hospitalier Universitaire de la Réunion